Becoming a Force in Digital Health.
What’s New at RF Health
What is Your Mobility Program? (And is it working?)
Today it is well accepted that mobility and movement are important parts of care in acute care hospitals. We have sufficient research and a growing…
Company Awards / Achievements
-
National Institutes of Health - Phase I Award
Small Business Innovative Research (SBIR) $300k Innovation Grant
Initial funding supports the development of wearable technology to reduce the risk of DVT and increase patient compliance.
-
National Institutes of Health - Phase II Award
Small Business Innovative Research (SBIR) $1.8M Innovation Grant
Validation of wearable technology to reduce the risk of DVT and optimize mobility measurement.
-
Top Cardiac and Vascular Disorder Startup 2021
The Cardiac and Vascular Disorders has over 2.2K+ startups that comprise of companies that engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of cardiac and vascular disorders.
Recovery Force made a curated list of the most promising startups leading the Cardiac and Vascular Disorders industry, from across the globe.
+ Disclaimer/Acknowledgement
Research reported in this presentation was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Numbers R43HL132624 & R44HL132624. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Grant number R43HL132624 financed jointly with 83 percent government ($244,167) and non-governement ($50,000) funding. Grant number R44HL132624 financed with 100 percent government ($1,763,777) funding.